Stockreport

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025

Organon & Co.  (OGN) 
PDF Full year 2025 revenue of $6.2 billion, down 3% on both an as-reported basis and at constant currencyFull year 2025 diluted earnings per share of $0.72 and non-GAAP Adju [Read more]